Document is current
Any future updates will be listed below
-
Authors
Ananya, Ananya
Holden, Kaitlyn G.
Gu, Zhiling
Nettleton, Dan
Mallapragada, Surya K.
Wannemuehler, Michael J.
Kohut, Marian L.
Narasimhan, Balaji
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 AI154458, R01 AI154458, R01 AI154458, R01 AI154458, R01 AI154458, R01 AI154458, R01 AI154458, R01 AI154458)
- License Information
-
More Information
Article History
Received: 11 October 2022
Accepted: 5 February 2023
First Online: 9 March 2023
Declarations
:
: All procedures involving animals were approved by the Institutional Animal Care and Use Committee at Iowa State University under protocol #IACUC-20-199.
: Not applicable.
: Balaji Narasimhan and Michael Wannemuehler are co-founders of ImmunoNanoMed Inc., a start-up with business interests in the development of nano-based vaccines against infectious diseases. Narasimhan also has a financial interest in Degimflex LLC. Surya Mallapragada is a co-founder of Degimflex LLC., a start-up with business interests in the development of flexible degradable electronic films for biomedical applications. She also has a financial interest in ImmunoNanoMed Inc.
